Biopharmx Corp (NYSEAMERICAN:BPMX – Get Free Report)’s share price was down 9.5% during mid-day trading on Monday . The company traded as low as $0.46 and last traded at $0.51. Approximately 4,038,100 shares traded hands during trading, an increase of 88% from the average daily volume of 2,150,348 shares. The stock had previously closed at $0.56.
Biopharmx Stock Performance
Biopharmx Company Profile
BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).
Featured Articles
- Five stocks we like better than Biopharmx
- How to Use Stock Screeners to Find Stocks
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with MarketBeat.com's FREE daily email newsletter.
